Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Cardiologist named in lawsuit not backing down | Type 2 diabetes & vascular damage | AFib and AVR outcomes

News You Need to Know Today
Cardiologist named in lawsuit not backing down | Type 2 diabetes & vascular damage | AFib and AVR outcomes
Friday, November 12, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Texas cardiologist named in lawsuit says he will not be 'silenced by corporate bullies’

The interventional cardiologist allegedly 'entered into a conspiracy' with other area providers to interfere with recruiting efforts. He has now responded to the allegations, however, and is not backing down. 

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Texas cardiologist named in lawsuit says he will not be 'silenced by corporate bullies’

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
The interventional cardiologist allegedly 'entered into a conspiracy' with other area providers to interfere with recruiting efforts. He has now responded to the allegations, however, and is not backing down. 
READ MORE >

We may finally know why type 2 diabetes is associated with vascular damage

New research published in Diabetes provides some potential answers to a big question. 

READ MORE >
Elderly patient doctor. Despite an expanded indication from the FDA and lower prices, patient access to these cholesterol-lowering medications remains a significant issue.
Share on Twitter Share on Facebook Share on Linkedin

We may finally know why type 2 diabetes is associated with vascular damage

Share on Twitter Share on Facebook Share on Linkedin
Elderly patient doctor. Despite an expanded indication from the FDA and lower prices, patient access to these cholesterol-lowering medications remains a significant issue.
New research published in Diabetes provides some potential answers to a big question. 
READ MORE >

How the presence of AFib can impact TAVR, SAVR outcomes

AVR patients may require a longer hospitalization if they present with pre-existing or new-onset AFib.

READ MORE >
HF-related mortality among older adults improved from 1999 to 2012, but then decreased considerably over the next several years. Researchers explored the latest data at length, sharing their findings in JACC: Heart Failure.
Share on Twitter Share on Facebook Share on Linkedin

How the presence of AFib can impact TAVR, SAVR outcomes

Share on Twitter Share on Facebook Share on Linkedin
HF-related mortality among older adults improved from 1999 to 2012, but then decreased considerably over the next several years. Researchers explored the latest data at length, sharing their findings in JACC: Heart Failure.
AVR patients may require a longer hospitalization if they present with pre-existing or new-onset AFib.
READ MORE >

'Remarkable' new findings suggest patients with diabetes should be screened for AFib

Patients who have type 1 or type 2 diabetes, it seems, are much less likely to notice symptoms related to an irregular heartbeat.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

'Remarkable' new findings suggest patients with diabetes should be screened for AFib

Share on Twitter Share on Facebook Share on Linkedin
Patients who have type 1 or type 2 diabetes, it seems, are much less likely to notice symptoms related to an irregular heartbeat.
READ MORE >

Mental stress–induced myocardial ischemia elevates risk of CV events

The study's authors wrote that additional research is warranted to assess whether testing for mental stress–induced ischemia provides value.

READ MORE >
New research out of the Yale School of Public Health suggests that patients taking beta-blockers or antiplatelet medications may want to be extra careful in warmer weather.
Share on Twitter Share on Facebook Share on Linkedin

Mental stress–induced myocardial ischemia elevates risk of CV events

Share on Twitter Share on Facebook Share on Linkedin
New research out of the Yale School of Public Health suggests that patients taking beta-blockers or antiplatelet medications may want to be extra careful in warmer weather.
The study's authors wrote that additional research is warranted to assess whether testing for mental stress–induced ischemia provides value.
READ MORE >

Featured Articles

Life expectancy lower among SAVR patients than the general public

Should patients be undergoing SAVR earlier? Is poor follow-up care partially to blame? 

READ MORE >
New research presented at the 103rd Annual Meeting of the American Association for Thoracic Surgery examined the lack of diversity seen among this important specialty. 
Share on Twitter Share on Facebook Share on Linkedin

Life expectancy lower among SAVR patients than the general public

Share on Twitter Share on Facebook Share on Linkedin
New research presented at the 103rd Annual Meeting of the American Association for Thoracic Surgery examined the lack of diversity seen among this important specialty. 
Should patients be undergoing SAVR earlier? Is poor follow-up care partially to blame? 
READ MORE >

New survey examines the biggest issues impacting care for CAD, PAD patients

Physicians, industry leaders—and, yes, patients themselves—provided an updated look at the state of vascular care in 2021. 

READ MORE >
Patient doctor with masks. A team of specialists from Cleveland Clinic reviewed nearly 3,000 medications, writing that a common type 2 diabetes medication offered the most potential as an effective treatment for AFib. 
Share on Twitter Share on Facebook Share on Linkedin

New survey examines the biggest issues impacting care for CAD, PAD patients

Share on Twitter Share on Facebook Share on Linkedin
Patient doctor with masks. A team of specialists from Cleveland Clinic reviewed nearly 3,000 medications, writing that a common type 2 diabetes medication offered the most potential as an effective treatment for AFib. 
Physicians, industry leaders—and, yes, patients themselves—provided an updated look at the state of vascular care in 2021. 
READ MORE >

Combined genetic testing for cardiomyopathies and arrhythmias yields positive results

The new findings come from research to be presented at AHA Scientific Sessions 2021. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Combined genetic testing for cardiomyopathies and arrhythmias yields positive results

Share on Twitter Share on Facebook Share on Linkedin
The new findings come from research to be presented at AHA Scientific Sessions 2021. 
READ MORE >

This is when you should sleep if you want to limit your risk of heart disease

Going to bed after midnight, researchers found, may adversely impact heart health.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

This is when you should sleep if you want to limit your risk of heart disease

Share on Twitter Share on Facebook Share on Linkedin
Going to bed after midnight, researchers found, may adversely impact heart health.
READ MORE >

In Other News

AI model diagnoses COVID-19 in routine blood tests with impressive accuracy

“With new mutations of the virus with higher transmission rates, it is imperative to diagnose positive cases as quickly and accurately as possible,” researchers wrote. 

READ MORE >
Hypertension patients measured their blood pressure less frequently during the early months of the COVID-19 pandemic, according to new research published in Hypertension. In addition, when those patients did measure their blood pressure, the readings were less healthy than they had been before the pandemic.
Share on Twitter Share on Facebook Share on Linkedin

AI model diagnoses COVID-19 in routine blood tests with impressive accuracy

Share on Twitter Share on Facebook Share on Linkedin
Hypertension patients measured their blood pressure less frequently during the early months of the COVID-19 pandemic, according to new research published in Hypertension. In addition, when those patients did measure their blood pressure, the readings were less healthy than they had been before the pandemic.
“With new mutations of the virus with higher transmission rates, it is imperative to diagnose positive cases as quickly and accurately as possible,” researchers wrote. 
READ MORE >

FDA recalls 2.2M at-home COVID tests due to false positive results

Ellume was the first company to gain federal authorization for an over-the-counter test to detect COVID-19.

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

FDA recalls 2.2M at-home COVID tests due to false positive results

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
Ellume was the first company to gain federal authorization for an over-the-counter test to detect COVID-19.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

New heart failure device impresses | Cardiac amyloidosis in the spotlight | Experts agree: HFmrEF should not be ignored
Cardiology salaries outpace other specialties | A new TAVR technique | Cardiac amyloidosis in the spotlight | BP drug recalled
A new device warning after 3 deaths | AI predicts stroke risk | FDA clears intravascular imaging tech | IV fluids recalled
Top 10 most popular radiology video interviews this past month
Cardiac ablations in ASCs | Shockwave's new IVL catheter | Clopidogrel resistance | Sex dreams & the heart | AI for stroke risk
Heartflow sues AI rival Cleerly | Another win for opportunistic screening | Predicting TAVR outcomes | Key approvals for Abbott
Is TAVR too common among younger patients? | New-look heart failure device delivers | SCAI to study women in the cath lab

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …5
    • Page 6
    • Page 7
    • Page 8
    • Current page 9
    • Page 10
    • Page 11
    • Page 12
    • Page 13 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme